Relmada Therapeutics, Inc. RLMD Occupancy and Related Charges
Occupancy and Related Charges at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s occupancy and related charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s occupancy and related charges?
- Relmada Therapeutics, Inc. (RLMD) reported occupancy and related charges of $45.7K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s occupancy and related charges changed year-over-year?
- Relmada Therapeutics, Inc.'s occupancy and related charges increased by 2.0% year-over-year, from $44.8K to $45.7K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s occupancy and related charges?
- Over 2 years (2023 to 2025), Relmada Therapeutics, Inc.'s occupancy and related charges has grown at a -8.0% compound annual growth rate (CAGR), from $225.5K to $190.7K.
- What does occupancy and related charges mean?
- The total expense recognized in the income statement related to operating lease agreements. It reflects the cost of utilizing leased assets over the reporting period, excluding capital lease obligations.